Inhibitors of kinases and their cognate phosphatases are of considerable pharmaceutical interest for a wide variety of disease targets11,12) and numerous specific biochemical assays have been developed for high throughput screening.
Some of the compounds known to inhibit eukaryotic protein kinases have been tested for effects on various developmental activities of Streptomyces griseus13) Staurosporine and compound K-252a are global inhibitors of eukaryotic protein kinases (probably because they bind at the ATP binding site in the catalytic region) and both these compounds inhibited phosphorylation of S. griseus proteins in in vitro labelling studies. Additionally, herbimicin and radicicol, thought to be specific inhibitors of tyrosine kinases, inhibited the phosphorylation of a streptomycete protein in an in vitro kinase assay; inhibition of tyrosine phosphorylation by these two compounds in other systems has since been shown to be an indirect effect14). Staurosporine and K-252a were found to inhibit the formation of aerial hyphae and spore formation, pigment production and production of the antibiotic streptomycin by S. griseus. Growth of vegetative mycelia was not affected. These compounds did not inhibit phosphotransfer when tested in E. coli. Such observations lend further support to the hypothesis that Streptomyces spp. employ eukaryotic-like signalling systems in developmental processes in addition to conventional prokaryotic two-component regulatory systems, and suggested to us that it might be possible to develop an assay employing streptomycetes to screen for a broad range of inhibitors of eukaryotic signal transduction. A number of streptomycetes were examined and the strain Streptomyces 85E with good growth and developmental characteristics on solid medium was found to be especially suited for such an Characterization of Isolates Strains of interest were characterized by fatty acid methyl ester (FAME)15) and 16S rDNA sequence16, 17) analyses. Samples were prepared for gas chromatography according to the protocol recommended for the MIDI automated microbial identification system and were phenyl methyl silicone fused capillary column on an HP 6890 system. Fatty acid profiles were compared to those in the MIDI aerobic bacteria database (MIDI, Inc., Newark, Delaware).
Primers for PCR amplification of 16S rDNA genes were GAGAGTTTGATCCTGGCTCAG (primer 16S.0007. Inhibition Assay Sterile 6mm filter paper discs (Schleicher and Schuell) were dipped into aqueous solutions of crude samples; compounds, known amounts were dispensed to the discs in to application of the disc to the test culture. ISP 4 (Difco)
plates were evenly spread with mycelial fragments of Streptomyces 85E from an overnight culture grown in tryptic soy broth and discs containing test samples were placed immediately onto these freshly seeded plates and hours on this medium and plates are optimally scored for effects on development at about 36 to 48 hours after inoculation.
Inhibition studies with the other bacterial tester strains employed standard disc diffusion assays on bacterial lawns.
M. tuberculosis).
Kinase Inhibition Assays
Kinase inhibition assays were carried out with kits provided by Pierce (Rockford, IL) and kinases from Upstate Biotechnology (Lake Placid, NY) were used according to the manufacturer's instructions.
Isolation and Identification of Active Compounds
General Methods Preparative chromatography procedures were done with a Beckman HPLC instrument and system Gold software. A Hewlett-Packard HP-MSD-1100 system was used for columns were used. An atmospheric pressure ionizationelectrospray (+ve) mass detector was used for routine analysis. NMR spectra were recorded in CDCL3, Cd3OD and DMSO-d6. 1H NMR (400 and 500MHz), 13C NMR (125 MHz) and HMBC, NMQC spectra were obtained on a Bruker NMR spectrometer while 13C NMR (75MHz) was obtained on a Varian NMR spectrometer. Both high and low resolution FAM-MS were measured on a Kratos concept II HQ mass spectometer. Amino acid analyses were obtained with the Applied Biosystems Aminoacid Analysis model 420A/H. Selected soil isolates identified by the assay as producers of inhibitors were grown to stationary phase in cultures up to 10 litres in tryptic soy broth (Difco). Supernatants and cell pellets were extracted separately with ethyl acetate and 10-20% methanol in ethyl acetate respectively. After concentrating both extracts and determining their activity, they were pooled and fractionated on a low mesh silica gel column, eluting with chloroform in an increasing methanol gradient.
Surfactin and Viscosin Inhibitory activity in fractions from Bacillus 60A and (i) Cyclomarin A Streptomyces D22-7B was determined to be a producer of cyclomarin A, previously identified from a marine source21). This heptapeptide was the compound responsible for sporulation inhibition by the crude culture broth.
(ii) Depsidomycin Streptomyces 154M produced an active inhibitor of 85E sporulation that was isolated by organic solvent extraction. Extensive purification yielded a pure active compound with a molecular weight of m/z 791. The molecular formula of TDI-12 was determined to be C38H65N9O9. Comparison of spectral data with the values published for depsidomycin and amino acid analysis22) confirmed the assignment. 
Results

Detection of Inhibitory Activity in
Bacterial Culture Supernatants A collection of Streptomycetes was screened for sensitivity to known protein kinase inhibitors. A strain isolated from a wash of a lichen sample collected in British Columbia designated WEC478-85E (hereinafter strain 85E), identified as a novel Streptomyces by 16S ribosomal DNA sequencing, was found to be exceptionally sensitive to the effects of compounds which inhibit aerial hyphae formation ( Figure 1 ). This strain has been deposited with the American Type Culture Collection (ATCC 55824).
Streptomyces 85E sporulates very readily when grown on a minimal medium such as ISP4 but does not sporulate on tryptic soy agar.
The aerial hyphae assay has been employed to screen over two thousand bacterial culture supernatants for inhibitory activity. One hundred strains were found to produce compounds which prevented sporulation of Streptomyces 85E. Similarly, a number of known or suspected kinase inhibitors have been tested for inhibition of 85E sporulation.
Identification of Active Compounds
From the group of 100 active soil isolates, five highly active culture supernatants (large zones of sporulation inhibition) were selected for purification of the inhibitory compounds. Two of the producing strains were nonactinomycetes while the remaining three were Streptomyces.
Isolate 60A is a Gram-positive, spore forming rod shaped bacterium. FAME analysis identified the strain as a Bacillus species with a similarity index value of 0.154 to Bacillus subtilis. The analysis of partial 16S rDNA sequence from this strain showed greatest homology to Bacillus licheniformis 16S rDNA (94% identity over 400 bases). The inhibitory compound was determined to be surfactin by comparison with an authentic sample (Sigma). Isolate 11C is a Gram-negative thin rod shaped bacterium. FAME analysis identified the strain as a Pseudomonas species and partial 16S rDNA sequence data showed greatest similarity to P. putida (98% identity over 432 bases). This strain and two other Pseudomonads produced the inhibitory compound viscosin20). The majority The inhibitory effect on sporulation was persistent, lasting for at least 3 to 4 days after the unaffected areas of the culture had sporulated (Fig. 1) . Surfactin at the concentrations tested was inactive against B. subtilis, S. aureus or E. coli tester strains.
Viscosin, depsidomycin, pyridomycin and cyclomarin A were also identified as specific and highly effective inhibitors of Streptomyces 85E development in the absence of generalised bactericidal activity ( Table 1) . None of these natural products had been demonstrated to have activity as potential protein kinase inhibitors. A large culture collection of fungi and actinomycetes has been screened for inhibitory activity against isolated enzymes such as a bacterial histidine kinase25), as well as for inhibitors of cytokine production and signalling in cellbased assays of macrophage activation26,27) and CD28 signal transduction28). Several of the identified compounds were active in inhibiting sporulation of Streptomyces 85E (Table 3 ) with the two most active being inhibitors of macrophage activation and CD28 signal transduction. A potent inhibitor of a bacterial histidine kinase (XR587) inhibited growth of Streptomyces 85E with no discernible effect on sporulation. The two compounds most active against 85E were also capable of inhibiting growth of mycobacterial test strains (see below). XR774, the principal inhibitor found in the CD28 signalling assay, was specific in its antimycobacterial activity having no effect on B. subtilis growth, whereas XR379 also inhibited B. subtilis (Table 3) .
Effects of Sporulation Inhibitors on Mycobacteria
The compounds described above were tested for inhibition of several mycobacterial strains. Mycobacteria have been shown to contain eukaryotic-like protein kinase genes29) and it was of interest to see if inhibitors of development isolated from streptomycetes would interfere with the growth of mycobacteria. The results are shown in Tables 1 and 3 . It should be noted that surfactin and viscosin had only weak activity against some strains but pyridomycin and cyclomarin A were good inhibitors of M. tuberculosis. Cyclomarin A was previously identified as a product of a marine organism21); this is the first report of its isolation from a terrestrial streptomycete. -: no effect seen
The effects on development, measured as a zone of sporulation inhibition, recorded for Streptomyces strain 85E were were recorded as growth inhibition zones following application of similar quantities of each pure compound to the test disc. 
Discussion
There is increasing realization of the importance of signal transduction pathways in the maintenance of normal and aberrant cellular functions; they are potential targets for pharmaceutical intervention. There may be as many as 1000 protein kinases encoded by the human genome and together with their cognate phosphatases they present a plethora of targets for drug development for the treatment of cancer, immune, cardiovascular, neural and other diseases11). Natural products of microorganisms have shown potential to act as specific agents for inhibiting components of these pathways and identification of such compounds is an active area of drug discovery30). Similarly, the involvement of signalling processes in host infection by bacterial and fungal pathogens provides targets for novel therapies of infectious diseases31).
Conventional assays for inhibitors of kinases and phosphatases often rely on the assessment of activity of pure enzymes in vitro32). Such assays are subject to a number of limitations and disadvantages. The purified enzymes and their substrates are often expensive and assay protocols often involve radioisotopes. The screening of microbial extracts as sources of inhibitors is often compromised by the presence of proteases and phosphatases which interfere with enzyme inhibition assays. Additionally, components of culture media are known to produce non-specific inhibitory effects. The development of a robust primary screening procedure that will detect inhibitors of protein modification directly and without interference is desirable and such a method is described here. This cell-based assay is a simple and inexpensive alternative to in vitro enzyme assays for the evaluation of large numbers of crude preparations from a variety of sources, including microbial and plant extracts, and combinatorial chemistry libraries. In addition, the "85E" assay system permits the ready identification of cytotoxic activity.
The "85E" assay system may be useful as a screening tool for inhibitors of a variety of signalling pathways. HONG et al. 13) 
